Vireo Growth (VREOF) Acquisitions (2025 - 2026)

Vireo Growth (VREOF) posted Acquisitions of -$18.2 million for Q1 2026, down 207.15% sequentially from -$5.9 million in Q4 2025.

Vireo Growth (VREOF) Acquisitions (2025 - 2026) Analysis & Trends

Vireo Growth has reported Acquisitions for 2 years, with the latest figure at -$18.2 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn	-
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-	-
10	Vireo Growth	482.88 Mn	340.58 Mn	95.30 Mn	80.20 Mn

Download Data